Kocuria rhizophila Kovacs et al. (ATCC® CRM-9341)

Strain Designations: FDA strain PCI 1001  /  Type Strain: no  /  Biosafety Level: 1

Permits And Restrictions

View Permits

Deposited As Sarcina lutea (Schroeter) Schroeter
Strain Designations FDA strain PCI 1001
Application For use in testing and calibration in ISO 17025 accredited laboratories, to challenge assay performance, validate or compare test methods, and to establish sensitivity, linearity and specificity during assay validation or implementation. ISO Guide 34:2009
Assay of [92303]
Assay of amoxicillin
Assay of ampicillin
Assay of clindamycin
Assay of cyclacillin
Assay of erythromycin
Assay of fungicide residues
Assay of lincomycin
Assay of novobiocin
Assay of oleandomycin
Assay of penicillamine
Assay of penicillin
Assay of rifamycins rifamycin
Assay of tylosin
Detection of [92259]
Media testing
Membrane filter testing
Produces 6-aminopenicillanic acid
Produces sorbosone L-sorbosone
Quality control strain
Sterility testing
Susceptibility disc testing chloramphenicol
Susceptibility disc testing doxycycline hydramycin
Susceptibility disc testing tetracycline
Isolation
Soil
Type Strain no
Biosafety Level 1
Product Format freeze-dried
Intended Use

 

 

Certified Reference Material produced under an ISO Guide 34:2009 accredited process.

 

    ACLASS Accredited Reference Material Producer AR-1384

Preceptrol® no
Genome Sequenced Strain

Yes

Type Strain no
Comments Certificates of Analysis are available electronically at www.atcc.org, or by hardcopy upon request.

Certified Reference Material produced under an ISO Guide 34:2009 accredited process.

Genome sequenced strain 

Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 30°C
Atmosphere: Aerobic
Name of Depositor FDA
Special Collection NSF - Bacteriology
Chain of Custody
ATCC <-- FDA <-- ER Squibb & Sons
Isolation
Soil
References

Makover S, Pruess DL. Method for producing L-sorbosone. US Patent 3,912,592 dated Oct 14 1975

British Pharmacopoeia Commission Biological assay of antibiotics. London, UK:British Pharmacopoeia Commission;British Pharmacopoeia Appendix XIV A, 2003

European Pharmacopoeia Commission Microbiological assay of antibiotics. Strasbourg, France:European Pharmacopoeia Commission;European Pharmacopoeia EP 2.7.2, 1997

U.S. Food & Drug AdministrationInhibitory substances in milk, Sarcina lutea cylinder plate methodIn: U.S. Food & Drug AdministrationBacteriological analytical manual8th ed.Gaithersburg, MDAOAC Internationalpp. 20.01-20.04, 1995

US Food & Drug Administration. GENERAL BIOLOGICAL PRODUCTS STANDARDS; General Provisions; Sterility Code of Federal Regulations Title 21: 21CFR610.12, Subpart B, 2005

AOAC International Antibiotics in feeds, microbiological methods. Gaithersburg, MD:AOAC International;AOAC "Official Methods of Analysis of the AOAC International" 957.23.

Noya F, et al. Heme compounds as iron sources for nonpathogenic Rhizobium bacteria. J. Bacteriol. 179: 3076-3078, 1997. PubMed: 9139934

Tang JS, Gillevet PM. Reclassification of ATCC 9341 from Micrococcus luteus to Kocuria rhizophila. Int. J. Syst. Evol. Microbiol. 53: 995-997, 2003. PubMed: 12892116

Inhibitory Substance in Milk. Washington, DC:US Food & Drug Administration;Bacteriological Analytical Manual Online Chapt. 20A, 2001

Microbial assay for antibiotics. Tokyo, Japan:Japanese Pharmacopoeia;JP JP14e.part I.34.

Sterility test, Growth promotion test. Tokyo, Japan:Japanese Pharmacopoeia;JP JP14e.part I.54.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation